Skip to main content
  • University of California, Los Angeles
Home
  • About Us
  • Research
    • Funding
    • Publications
  • Lab Members
  • News
    • In the Media
  • Contact Us
  • University of California, Los Angeles

Search

Try looking up topics of interest.

Breadcrumb
  1. Home
  2. Articles
  3. Dry Powder Inhalers: A Double Win for COPD and Environment

Dry Powder Inhalers: A Double Win for COPD and Environment

White handheld inhaler device with an open hinged cover, shown against a white background.
February 24, 2026
By U.S. News &World Report
1 min read

By Dennis Thompson HealthDay Reporter TUESDAY, Feb. 24, 2026 (HealthDay News) — Dry powder inhalers might provide a double benefit for people battling chronic obstructive pulmonary disease (COPD), a new study says.

Read the full article

Article Type
News
Share:
  • Facebook
  • X
  • LinkedIn

Related Articles

pills in blister containers

William Feldman, MD: Azithromycin Over Roflumilast in Real World COPD Data

August 19, 2026
1 min read
Pills: white tablets spilling from an orange bottle onto an Rx prescription form.

Azithromycin favored over roflumilast for protecting against COPD exacerbations

August 19, 2026
1 min read
X-ray Lungs showing chest cavity with trachea and branching bronchi

Good News — Researchers Just Found Which Drug Is Better to Treat COPD Flare-Ups

August 11, 2026
1 min read
White handheld inhaler device with an open hinged cover, shown against a white background.

Umeclidinium-vilanterol shows modest but consistent advantage among LAMA-LABA options in symptomatic COPD

May 06, 2026
1 min read
View All News and Highlights
Home

Feldman Lab 
UCLA Department of Medicine
David Geffen School of Medicine

  • Facebook
  • X-Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Emergency
  • Accessibility
  • UCLA Privacy Policy
  • UCLA Health Privacy Notice
  • Login
© 2026 UCLA Health